Participation in a relevant conference, dissemination of results (ADRR - The 12th Aging Research and Drug Discovery Meeting) - Copenhagen - August 25-29, 2025.

This tender concerns the funding or facilitation of participation in a specific scientific conference: The 12th Aging Research and Drug Discovery Meeting (ADRR). The conference is scheduled to take place in Copenhagen from August 25th to 29th, 2025. The primary purpose of this participation is the dissemination of research results. This implies that the individual or team attending the conference will present findings, likely through oral presentations or poster sessions, related to aging research and drug discovery. The tender may cover costs associated with registration, travel, accommodation, and potentially other related expenses for one or more delegates. The objective is to share scientific advancements, foster collaborations, and gain insights from the international research community in this specialized field. Potential bidders or participants are expected to be involved in relevant research and be capable of effectively presenting their work. The conference itself is a significant event for professionals and researchers in the field of aging and pharmaceutical development.

This is a consulting contract in the Research and health and medical services sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,052.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for consulting in the Research sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. This contract has already been awarded. The information is published for transparency and market intelligence purposes.